Article Details

Unity Biotechnology, Inc. (NASDAQ:UBX) Receives Average Rating of “Buy” from Analysts

Retrieved on: 2022-06-08 23:17:32

Tags for this article:

Click the tags to see associated articles and topics

Unity Biotechnology, Inc. (NASDAQ:UBX) Receives Average Rating of “Buy” from Analysts. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 389,893 shares of the company's stock worth $435,000 after buying an additional 111,097 shares during the period ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up